Form 8-K - Current report:
SEC Accession No. 0001558370-24-013889
Filing Date
2024-10-30
Accepted
2024-10-30 09:25:13
Documents
15
Period of Report
2024-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K viri-20241029x8k.htm   iXBRL 8-K 41440
2 EX-99.1 viri-20241029xex99d1.htm EX-99.1 12050
3 GRAPHIC viri-20241029xex99d1001.jpg GRAPHIC 4807
  Complete submission text file 0001558370-24-013889.txt   185129

Data Files

Seq Description Document Type Size
4 EX-101.SCH viri-20241029.xsd EX-101.SCH 3254
5 EX-101.LAB viri-20241029_lab.xml EX-101.LAB 15931
6 EX-101.PRE viri-20241029_pre.xml EX-101.PRE 10050
17 EXTRACTED XBRL INSTANCE DOCUMENT viri-20241029x8k_htm.xml XML 4900
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 241407713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)